Betaferon®. Wellenbrecher bei MS. - Neurologie ...

Neurologische Klinik NL
91. Theil DJ, Libbey JE, Rodriguez, Whitton JL, Tsunda I, Derfuss TJ, Fujinami RS. Targeting Myelin
proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of
experimental autoimmune encephalomyelitis. J Neuroimmunol 2008;204:92-100
92. Thürauf N, Gossler A, Lunkenheimer J, Lunkenheimer B, Maihöfner C, Bleich S, Kornhuber J,
Markovic K, Reulbach U. Olfactory lateralization: odor intensity but not the hedonic estimation
is lateralized. Neurosci Lett 2008;438:228-32.
93. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M,
Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO,
Toni D, Vanhooren G. Multivariable analysis of outcome predictors and adjustment of main
outcome results to baseline data profile in randomized controlled trials: Safe implemen-
tation of thrombolysis in stroke-monitoring study (sits-most). Stroke 2008;39:3316-22
94. Waschbisch A, Winterle S, Lochmüller H, Walter MC, Wischhusen J, Kieseier BC, Wiendl H.
Human muscle cells express the costimulatory molecule B7-H3, which modulates muscleimmune
interactions. Arthritis Rheum 2008;58:3600-8
95. Winner B, Rockenstein E, Lie DC, Aigner R, Bogdahn U, Couillard-Depres S, Masliah E,
Winkler J. Mutant -synuclein exacerbates age-related decrease of neurogenesis.
Neurobiol Aging 2008;29:913-25
96. Winner B, Couillard-Despres S, Geyer M, Aigner R, Bogdahn U, Aigner L, Kuhn HG, Winkler J.
Dopaminergic deficit potentates EGF and FGF-2 induced neuroblast migration towards
non-neurogenic regions. J Neuropath Exp Neurol 2008;67:105-16
97. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S,
Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL,
Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Köhrmann M, Koroshetz W, Lee TY, Lees K,
Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger PD, Silbergleit R,
Sorensen AG, Wardlaw J, Wu O, Warach S. Acute Stroke Imaging Roadmap.
Stroke 2008;39(5): 1621-1628
98. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S,
Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL,
Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Köhrmann M, Koroshetz W, Lee TY,
Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P,
Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S. Acute stroke imaging research
roadmap. AJNR Am J Neuroradiol 2008;29:23-30
99. Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D. Effects of levetiracetam as an add-on
therapy on cognitive function and quality of life in patients with refractory partial seizures.
Epilepsy Behav 2008;12:305-10.
Jahresbericht 2008/09
71